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Abstract In order to get a better insight into the function of
amino acid residues located in the second transmembrane domain
of the cystic fibrosis transmembrane conductance regulator
(CFTR) protein, all exon 18 mutations found in cystic fibrosis
(CF) patients were characterized at the protein and at the
electrophysiological level. Of the different mutations present in
transmembrane helix 12 (M1137V, M1137R, I1139V and
vM1140), and the intracytoplasmic loop connecting TM12 and
NBD2 (D1152H and D1154G), only M1137R interfered with the
proper maturation of the protein. Permeability studies performed
after injection of the different wild-type and mutant cRNAs in
Xenopus laevis oocytes indicated that the mutations did not alter
the permeability sequence of the CFTR channels. The whole cell
cAMP activated chloride currents, however, were significantly
reduced for M1137V, I1139V, D1152H and D1154G and close
to zero for vM1140, indicating that these mutations interfere
with the proper gating of the chloride channels.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Cystic ¢brosis (CF), an autosomal recessive disorder char-
acterized by alterations in transepithelial salt transport [1], is
caused by mutations in the cystic ¢brosis transmembrane con-
ductance regulator gene (CFTR) [2^4]. This gene encodes a
symmetrical multidomain protein, each half composed of a
transmembrane domain (TMD) and a nucleotide binding do-
main (NBD), separated by a highly charged regulatory (R)
domain. The protein forms a channel through which chloride
ions permeate downwards an electrochemical gradient. Acti-
vation of the chloride channel occurs via di¡erent steps [5].
First, the R domain becomes phosphorylated by protein kin-
ase A (PKA). In a second step, ATP is bound and hydrolyzed
by the ¢rst nucleotide binding domain such that the channel
opens and chloride ions are transported. Binding and hydrol-
ysis of ATP at NBD2 will close the channel. How these di¡er-
ent events are linked to each other is not completely clear yet.
Mutagenesis studies of amino acid residues located in the
di¡erent cytoplasmatic loops connecting the transmembrane
helices indicated that these residues were important for the
opening of the channel and that they might form the link
between the nucleotide binding domains and the conducting
pore [6^10].
The anion selectivity ¢lter itself seems to be formed by the
transmembrane helices [11], since mutagenesis of lysine 95 to
aspartate and of lysine 335 to glutamate changed the anion
selectivity of the channel. These data could, however, not be
con¢rmed [12]. Deletion constructs, lacking the ¢rst four heli-
ces, gave rise to functional cAMP regulated chloride channels
with ion selectivities identical to wild-type CFTR [13]. These
¢ndings indicated that only the ¢fth and the sixth helix of
TMD1 were essential components of the conductive pore
and the selectivity ¢lter of CFTR. Scanning-cysteine-accessi-
bility analysis, however, substantiated the ¢ndings of Ander-
son et al. [11] : amino acids residing in the ¢rst and sixth
transmembrane helix take part in the formation of the ion
pore. Moreover, residues located in the region of amino acids
351 and 353 seem to determine the anion-cation selectivity of
the CFTR chloride channel [14].
When both halves of the protein (TMD1-NBD1-R and
TMD2-NBD2) are expressed alone, no functional chloride
channel can be detected using SPQ halide e¥ux assays [15].
When more sensitive techniques like patch clamp analysis
were used, however, cAMP dependent chloride channels could
be detected in cells expressing TMD1-NBD1-R alone [16,17].
When both halves of the protein were co-expressed, chloride
transport could already be detected using SPQ assays and co-
immunoprecipitation studies indicated that both halves inter-
acted with each other. For this interaction, the presence of
TMD2 and only the ¢rst two transmembrane helices of
TMD1 were su⁄cient. These ¢ndings indicated that TMD1
and TMD2 may mediate association between the two halves
of the protein [15].
In contrast to TMD1, the importance of TMD2 in ion pore
formation and ion selectivity has not been studied in detail. In
order to get a better insight into the structure and function of
TMD2, we studied disease causing mutations located in TM12
and in the loop connecting TM12 and NBD2, both at the
protein and at the electrophysiological level.
2. Materials and methods
2.1. Plasmid construction
A XhoI-KpnI fragment containing the CFTR coding region was
isolated out of the prokaryotic vector pTG5960 (Transgene) and in-
serted in the eukaryotic expression vector pcDNA3 (Invitrogen). Six
di¡erent mutations: a3541g ( = M1137V), t3542g ( = M1137R), a3547g
( = I1139V), deletion of atg from 3550 ( =vM1140), g3586c
( = D1152H) and a3593g ( = D1154G) were introduced using the
Transformer Site-Directed Mutagenesis kit (Clontech). The complete
CFTR coding region of the wild type and the six mutant constructs
was characterized by dideoxy sequencing. The di¡erent constructs
only contained the introduced mutations.
2.2. Expression, pulse chase and immunoprecipitation of CFTR
Twenty Wg of plasmid DNA was electroporated (Bio-Rad Gene
Pulser, Bio-Rad Laboratories, Hercules, CA, USA) into 1.5^3U107
COS1 cells. The transfected cells were cultured for 48^72 h at 37‡C in
DMEM F12 (Life Technologies, Inchinnan, Scotland, UK) supple-
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mented with 10% fetal bovine serum (HyClone Laboratories, Logan,
UT, USA) and subsequently selected with G418 disulfate (480 mg/l;
Duchefa, Haarlem, The Netherlands). After 2 weeks of selection, the
cells were starved for 30 min in RPMI 1640 medium (Life Technolo-
gies, Inchinnan, Scotland, UK) without methionine and cysteine, la-
belled during a 30-min pulse in RPMI 1640 supplemented with 100
mCi/ml [35S]methionine and [35S]cysteine (ICN Pharmaceuticals, Cos-
ta Mesa, CA, USA) and ¢nally chased for di¡erent time periods in
DMEM F12 supplemented with 10% fetal bovine serum. Cells were
scraped and subsequently lysed by sonication in ice cold IPPA-bu¡er
(20 mM Tris, 150 mM NaCl, 1% Na-desoxycholate, 1% Triton X-100,
0.1% SDS, pH 7.4) supplemented with protease inhibitors (20 mg/ml
soybean trypsin inhibitor, 1 mg/ml leupeptin, 1 mg/ml antipain, 1 mg/
ml chymostatin and 1 mM phenylmethylsulfonyl£uoride). The lysate
was precleared with protein A-Sepharose CL-4B beads (Pharmacia
Biotech, Uppsala, Sweden) and CFTR proteins were a⁄nity puri¢ed
by incubation for one hour with an anti-CFTR monoclonal antibody
directed against the C-terminal part of CFTR (Genzyme Diagnostics,
Cambridge, MA, USA). The immunocomplexes were puri¢ed on pro-
tein A-Sepharose CL-4B beads and after addition of loading bu¡er
(1% L-mercaptoethanol, 16 mM Tris-HCl, pH 6.8, 4% SDS, bromo-
phenol blue and 10% glycerol) loaded on a 4^12% SDS gel (Novex,
San Diego, CA, USA). After drying, the gel was exposed at 370‡C to
a light sensitive ¢lm for 3^4 h.
2.3. In vitro transcription
The di¡erent CFTR-constructs were in vitro transcribed using the
T7 RiboMAX Large Scale RNA Production System (Promega, Mad-
ison, WI, USA), according to the protocol of the manufacturer. The
quality of the RNA was determined by means of formaldehyde-agar-
ose (1%) gel electroporesis.
2.4. RNA injection in oocytes
Female toads (Xenopus laevis) were anaesthetized in ice cold water
containing 2 g/l 3-aminobenzoic acid ethylester (Sigma-Aldrich, Bor-
nem, Belgium) and oocytes were subsequently collected via abdominal
excision. The oocytes were incubated in a calcium-free solution con-
taining 2 mg/ml collagenase A (Boehringer Mannheim, Mannheim,
Germany) for 1 h. The oocytes were injected with 50 nl in vitro tran-
scribed RNA (5 Wg/Wl).
2.5. Two-electrode voltage-clamp assays
Three days after RNA injection, oocytes were mounted in a perfu-
sion chamber, impaled with two electrodes and voltage clamped. In
order to block endogenous Ca2-activated chloride currents, the per-
fusion solution (96 mM NaCl, 5 mM HEPES, 2 mM KCl, 1.8 mM
CaCl2 and 1 mM MgCl2 ; pH 7.5) contained 100 WM ni£umic acid.
CFTR-currents were activated through addition of 10 WM forskolin
and 1 mM IBMX. Chloride currents were not activated in non-in-
jected, in water-injected or in oocytes injected with RNA derived from
in vitro transcribed pcDNA3. In order to determine the anion perme-
ability of the channel, chloride ions were substituted in the perfusion
solution by equimolar amounts of bromide or iodide. The anion per-
meability relative to that of Cl3 was calculated from shifts in reversal
potential, using the equation Px/PCl = ([Cl3]eWexp (vErevWF/
RWT)3[Cl3]res)/[X3]e in which [X3]e represents the extracellular iodide
or bromide concentration, [Cl3]e and [Cl3]res the intracellular and
‘residual’ extracellular concentrations (present in CaCl2 and MgCl2)
and vErev is the measured shift in reversal potential. All data were
analyzed by Student’s t-test. A value of P6 0.05 was considered as
signi¢cant. Data are reported as mean þ S.E.M.
3. Results and discussion
3.1. Maturation properties of the di¡erent mutants
Disease causing amino acid substitutions located in the
membrane spanning sequences or in the intracytoplasmic
loops can interfere both with the maturation and/or gating
properties of the corresponding CFTR protein. The e¡ect of
the di¡erent mutations located in exon 18 was therefore ¢rst
studied at the maturational level. To this e¡ect, COS1 cells
were transfected with the di¡erent mutant CFTR cDNAs, and
the expressed proteins were analyzed using pulse chase experi-
ments followed by immunoprecipitation. Fig. 1 shows that the
di¡erent mutants, except M1137R, exhibit the same matura-
tion pattern as wild-type CFTR. For M1137R, however, only
the 150-kDa form was detected, even after 3 h and 30 min of
chase time. This indicates that the core glycosylated M1137R
translation product is degraded in the ER before it can be
transported to the cell surface. This mutation introduces a
strong positively charged amino acid in an aliphatic chain
that spans the membrane. Therefore, it is very likely that
this mutation interferes with the proper insertion of the trans-
lation product in the membrane and will give rise to a mis-
folded protein that is recognized and degraded by the ER
control system. This hypothesis is substantiated by the ¢nding
that another mutation that a¡ects the same amino acid resi-
due, but that replaces it with an aliphatic one (M1137V),
exhibits a ‘wild-type’ maturation pattern. Strikingly, deletion
of amino acid M1140, located in the middle of transmem-
brane helix 12, does not a¡ect CFTR conformation such
that the protein is degraded by the quality control system.
3.2. Electrophysiological properties of the di¡erent mutants
Mutants that showed no maturation defect were subse-
quently analyzed at the electrophysiological level. Xenopus
laevis oocytes were injected with the di¡erent mutant and
wild-type cRNAs and whole cell currents were measured, be-
fore and after stimulation with forskolin and IBMX (Fig. 2A),
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Fig. 1. Pulse chase and immunoprecipitation of wild-type and mutant CFTR proteins from transfected COS1 cells. COS1 cells transfected with
wild-type, M1137V, M1137R, I1139V, vM1140, D1152H and D1154G CFTR were metabolically labelled, chased, CFTR was immunoprecipi-
tated and separated on an SDS-PAGE gel. The core-glycosylated (150 kDa) and mature (190 kDa) CFTR protein bands are indicated.
M1137V, M1137R, I1139V and vM1140 are located in transmembrane helix 12 and D1152H and D1154G are located in the intracytoplasmic
loop connecting TM12 and NBD2.
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using the two electrode voltage clamp technique. The channels
were characterized by a linear I-V relationship (Fig. 2B). Four
mutants, M1137V, I1139V, D1152H and D1154G showed a
signi¢cantly reduced current, when compared to wild type,
and two other mutants, M1137R and vM1140 were not acti-
vated by cAMP (Fig. 3). The absence of cAMP sensitive
chloride currents found for M1137R is most probably caused
by a defect in maturation, as found in COS1 cells. The under-
lying mechanism by which the deletion of amino acid M1140
disrupts chloride transport remains completely unknown. Giv-
en the crucial location of M1140 in the middle of TM12,
deletion of this amino acid might disrupt the ion pore such
that ion passage is completely blocked.
The e¡ect of mutations that only induced a reduction of the
cAMP inducible chloride current was then analyzed for their
in£uence on the permeation properties of the channel. Wild-
type CFTR was characterized by the following permeation
sequence: Br3sCI3s I3 (Fig. 2C). The same permeation
sequence was found for the four mutants, M1137V, I1139V,
D1152H and D1154G (Fig. 2D). Mutations D1152H and
D1154G are located in the intracytoplasmic loop that con-
nects TM12 and NBD2 and thus only a¡ect the cAMP indu-
cible whole cell currents. Since this loop connects the second
nucleotide binding domain with the transmembrane spanning
helices that form the pore of the channel, it might function in
the cascade of events that connect the cycles of binding and
hydrolysis of ATP to the opening and closing of the chloride
channel. Single channel measurements of these mutants are
needed to substantiate this hypothesis.
In summary, exon 18 CFTR mutations found in CF pa-
tients were functionally characterized. One mutation
(M1137R) did result in failure of protein maturation while
the remainder did a¡ect gating of the chloride channel.
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Fig. 3. Whole cell chloride currents measured in Xenopus laevis oo-
cytes expressing wild-type and mutant CFTR proteins. Xenopus lae-
vis oocytes were injected with in vitro transcribed wild-type and mu-
tant CFTR RNA and the basal (black bar) and cAMP (white bar)
induced chloride currents were measured by the two electrode volt-
age clamp technique 72 h later. Mutants that showed a signi¢cantly
di¡erent cAMP dependent chloride current (P6 0.05), compared to
wild-type CFTR, are marked with an asterisk and the number of
oocytes analyzed are indicated.
Fig. 2. The electrophysiological properties of CFTR injected Xenopus laevis oocytes. A: Time course of membrane currents at +50 mV in wild-
type CFTR injected oocytes. ‘cAMP’ indicates the time period during which 10 WM forskolin and 1 mM IBMX was applied. B: Current volt-
age relationships before (a) and during (b) application of 10 WM forskolin and 1 mM IBMX measured at the time points (a and b) indicated
by ¢lled triangles in A. C: Anion selectivity of cAMP activated Cl3 currents in wild-type CFTR injected Xenopus laevis oocytes. I/V relation-
ship was obtained from wild-type CFTR injected oocytes, incubated in ND-96 solution or anion-substituted ND-96 solution, after stimulation
with 10 WM forskolin and 1 mM IBMX. D: Comparison of the permeability ratios of wild-type and mutant CFTR by anion substitution.
Data are presented as mean þ S.E.M. (n = 4 for each group).
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